Article
BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer
26 Jan 2022
Abstract excerpt
Background: Biglycan (BGN) plays a role in the occurrence and progression of several malignant tumors, though its role in gastric cancer (GC) remains unclear. The objective of this study was to investigate BGN expression, its role in GC prognosis, and immune infiltration. Material and Methods: Gene expression data and corresponding clinical information were downloaded from TCGA and GTEx, respectively. We compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
